Published in Infect Immun on July 09, 2012
Lung microbiome and disease progression in idiopathic pulmonary fibrosis: an analysis of the COMET study. Lancet Respir Med (2014) 2.25
Enrichment of the lung microbiome with gut bacteria in sepsis and the acute respiratory distress syndrome. Nat Microbiol (2016) 1.43
The emerging world of the fungal microbiome. Trends Microbiol (2013) 1.40
Changes in the lung microbiome following lung transplantation include the emergence of two distinct Pseudomonas species with distinct clinical associations. PLoS One (2014) 1.39
The mycobiota: interactions between commensal fungi and the host immune system. Nat Rev Immunol (2014) 1.28
Fungi of the murine gut: episodic variation and proliferation during antibiotic treatment. PLoS One (2013) 1.11
Cell-associated bacteria in the human lung microbiome. Microbiome (2014) 1.02
Analysis of culture-dependent versus culture-independent techniques for identification of bacteria in clinically obtained bronchoalveolar lavage fluid. J Clin Microbiol (2014) 1.00
Murine models of Candida gastrointestinal colonization and dissemination. Eukaryot Cell (2013) 0.97
Improved characterization of medically relevant fungi in the human respiratory tract using next-generation sequencing. Genome Biol (2014) 0.96
Innocent until proven guilty: mechanisms and roles of Streptococcus-Candida interactions in oral health and disease. Mol Oral Microbiol (2014) 0.95
Fungal-bacterial interactions and their relevance to oral health: linking the clinic and the bench. Front Cell Infect Microbiol (2014) 0.91
Candida albicans Inhibits Pseudomonas aeruginosa Virulence through Suppression of Pyochelin and Pyoverdine Biosynthesis. PLoS Pathog (2015) 0.88
Modulation of post-antibiotic bacterial community reassembly and host response by Candida albicans. Sci Rep (2013) 0.86
Candida albicans and Enterococcus faecalis in the gut: synergy in commensalism? Gut Microbes (2013) 0.85
Characterization of Bacterial and Fungal Microbiome in Children with Hirschsprung Disease with and without a History of Enterocolitis: A Multicenter Study. PLoS One (2015) 0.85
Immunological Consequences of Intestinal Fungal Dysbiosis. Cell Host Microbe (2016) 0.84
Microorganisms linked to inflammatory bowel disease-associated dysbiosis differentially impact host physiology in gnotobiotic mice. ISME J (2015) 0.80
Mining the oral mycobiome: Methods, components, and meaning. Virulence (2016) 0.79
Use of direct gradient analysis to uncover biological hypotheses in 16s survey data and beyond. Sci Rep (2012) 0.78
Using Bayesian modelling to investigate factors governing antibiotic-induced Candida albicans colonization of the GI tract. Sci Rep (2015) 0.78
Candida albicans Pathogenesis: Fitting within the Host-Microbe Damage Response Framework. Infect Immun (2016) 0.76
Enterococcus faecalis bacteriocin EntV inhibits hyphal morphogenesis, biofilm formation, and virulence of Candida albicans. Proc Natl Acad Sci U S A (2017) 0.75
A stepwise introduction of a successful antimicrobial stewardship program. Experience from a tertiary care university hospital in Western, Saudi Arabia. Saudi Med J (2016) 0.75
Infant fungal communities: current knowledge and research opportunities. BMC Med (2017) 0.75
Interspecies Interactions between Clostridium difficile and Candida albicans. mSphere (2016) 0.75
Blunted dynamics of adenosine A2A receptors is associated with increased susceptibility to Candida albicans infection in the elderly. Oncotarget (2016) 0.75
The Fungal Mycobiome and Its Interaction with Gut Bacteria in the Host. Int J Mol Sci (2017) 0.75
Intestinal colonization by Candida albicans alters inflammatory responses in Bruton's tyrosine kinase-deficient mice. PLoS One (2014) 0.75
Specific Human and Candida Cellular Interactions Lead to Controlled or Persistent Infection Outcomes During Granuloma-like Formation. Infect Immun (2016) 0.75
Effect of Candida albicans on Intestinal Ischemia-reperfusion Injury in Rats. Chin Med J (Engl) (2016) 0.75
Fungal ITS1 Deep-Sequencing Strategies to Reconstruct the Composition of a 26-Species Community and Evaluation of the Gut Mycobiota of Healthy Japanese Individuals. Front Microbiol (2017) 0.75
Lactic acid bacteria differentially regulate filamentation in two heritable cell types of the human fungal pathogen Candida albicans. Mol Microbiol (2016) 0.75
Development of an antifungal denture adhesive film for oral candidiasis utilizing hot melt extrusion technology. Expert Opin Drug Deliv (2014) 0.75
Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl Environ Microbiol (2009) 77.55
Obesity alters gut microbial ecology. Proc Natl Acad Sci U S A (2005) 33.66
Bacterial diversity in human subgingival plaque. J Bacteriol (2001) 14.60
Symbiotic bacteria direct expression of an intestinal bactericidal lectin. Science (2006) 9.95
Reproducible community dynamics of the gastrointestinal microbiota following antibiotic perturbation. Infect Immun (2009) 7.48
Regulation of cell-surface genes and biofilm formation by the C. albicans transcription factor Bcr1p. Curr Biol (2005) 4.97
Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits. Nature (2008) 4.87
Mucosal damage and neutropenia are required for Candida albicans dissemination. PLoS Pathog (2008) 2.80
Enterococci at the crossroads of food safety? Int J Food Microbiol (1999) 2.19
Role of antibiotics and fungal microbiota in driving pulmonary allergic responses. Infect Immun (2004) 2.04
Ecology of Candida albicans gut colonization: inhibition of Candida adhesion, colonization, and dissemination from the gastrointestinal tract by bacterial antagonism. Infect Immun (1985) 2.03
Role of the microbiota in inflammatory bowel diseases. Inflamm Bowel Dis (2011) 1.95
Microbial interference between indigenous yeast and lactobacilli in the rodent stomach. J Bacteriol (1969) 1.91
Development of allergic airway disease in mice following antibiotic therapy and fungal microbiota increase: role of host genetics, antigen, and interleukin-13. Infect Immun (2005) 1.85
Self-regulation of Candida albicans population size during GI colonization. PLoS Pathog (2007) 1.85
Determination of the colonization resistance of the digestive tract of individual mice. J Hyg (Lond) (1974) 1.72
Colonization of the cecal mucosa by Helicobacter hepaticus impacts the diversity of the indigenous microbiota. Infect Immun (2005) 1.67
Candida albicans interactions with bacteria in the context of human health and disease. PLoS Pathog (2010) 1.48
Microbial ecology of the murine gut associated with the development of dextran sodium sulfate-induced colitis. Inflamm Bowel Dis (2010) 1.44
Effect of various antibiotics on gastrointestinal colonization and dissemination by Candida albicans. Sabouraudia (1985) 1.43
Natural history of Candida species and yeasts in the oral cavities of infants. Arch Oral Biol (1973) 1.34
Animal models of mucosal Candida infection. FEMS Microbiol Lett (2008) 1.33
Adaptations of Candida albicans for growth in the mammalian intestinal tract. Eukaryot Cell (2010) 1.32
Regulation of Candida albicans morphogenesis by fatty acid metabolites. Infect Immun (2004) 1.24
Effects of broad-spectrum antimicrobial agents on yeast colonization of the gastrointestinal tracts of mice. Antimicrob Agents Chemother (1990) 1.20
Murine model of concurrent oral and vaginal Candida albicans colonization to study epithelial host-pathogen interactions. Microbes Infect (2007) 1.15
Inhibition of Candida albicans by Escherichia coli in vitro and in the germfree mouse. J Surg Res (1973) 1.08
Interplay between the gastric bacterial microbiota and Candida albicans during postantibiotic recolonization and gastritis. Infect Immun (2011) 1.07
Colonization resistance of the digestive tract--mechanism and clinical consequences. Nahrung (1987) 1.02
In vivo virulence of Candida albicans isolates causing mucosal infections in people infected with the human immunodeficiency virus. J Infect Dis (2000) 0.99
The colonization resistance of the digestive tract in different animal species and in man; a comparative study. Epidemiol Infect (1990) 0.98
Probiotic effects of feeding heat-killed Lactobacillus acidophilus and Lactobacillus casei to Candida albicans-colonized immunodeficient mice. J Food Prot (2000) 0.96
Inhibition of Candida albicans by the anaerobic oral flora of mice in vitro. Sabouraudia (1981) 0.87
Resistance to acidic and alkaline environments in the endodontic pathogen Enterococcus faecalis. Oral Microbiol Immunol (2006) 0.86
Population changes of indigenous murine Candida pintolopesii under various experimental conditions and routes of inoculation. Appl Environ Microbiol (1988) 0.81
Intestinal candidiasis. A clinical report and comments about this opportunistic pathology. Mycopathologia (2002) 0.79
Reproducible community dynamics of the gastrointestinal microbiota following antibiotic perturbation. Infect Immun (2009) 7.48
Decreased diversity of the fecal Microbiome in recurrent Clostridium difficile-associated diarrhea. J Infect Dis (2008) 6.21
Analysis of the lung microbiome in the "healthy" smoker and in COPD. PLoS One (2011) 4.65
Clostridium difficile ribotype does not predict severe infection. Clin Infect Dis (2012) 4.34
Comparison of the respiratory microbiome in healthy nonsmokers and smokers. Am J Respir Crit Care Med (2013) 3.65
Decade-long bacterial community dynamics in cystic fibrosis airways. Proc Natl Acad Sci U S A (2012) 3.43
Does the microbiota regulate immune responses outside the gut? Trends Microbiol (2004) 2.69
From structure to function: the ecology of host-associated microbial communities. Microbiol Mol Biol Rev (2010) 2.42
A pilot study of the association of low plasma adiponectin and Barrett's esophagus. Am J Gastroenterol (2008) 2.39
The interplay between microbiome dynamics and pathogen dynamics in a murine model of Clostridium difficile Infection. Gut Microbes (2011) 2.37
Leptin-deficient mice exhibit impaired host defense in Gram-negative pneumonia. J Immunol (2002) 2.27
Changes in cystic fibrosis airway microbiota at pulmonary exacerbation. Ann Am Thorac Soc (2013) 2.05
Role of antibiotics and fungal microbiota in driving pulmonary allergic responses. Infect Immun (2004) 2.04
Evolutionary genetics of a new pathogenic Escherichia species: Escherichia albertii and related Shigella boydii strains. J Bacteriol (2005) 2.01
Leptin corrects host defense defects after acute starvation in murine pneumococcal pneumonia. Am J Respir Crit Care Med (2005) 1.97
Significance of the microbiome in obstructive lung disease. Thorax (2012) 1.97
Urease expression by Cryptococcus neoformans promotes microvascular sequestration, thereby enhancing central nervous system invasion. Am J Pathol (2004) 1.87
Association between Helicobacter pylori infection and inflammatory bowel disease: a meta-analysis and systematic review of the literature. Inflamm Bowel Dis (2010) 1.86
Alteration of the murine gut microbiota during infection with the parasitic helminth Heligmosomoides polygyrus. Inflamm Bowel Dis (2010) 1.85
Development of allergic airway disease in mice following antibiotic therapy and fungal microbiota increase: role of host genetics, antigen, and interleukin-13. Infect Immun (2005) 1.85
Prior Helicobacter pylori infection ameliorates Salmonella typhimurium-induced colitis: mucosal crosstalk between stomach and distal intestine. Inflamm Bowel Dis (2010) 1.84
Role of IFN-gamma in regulating T2 immunity and the development of alternatively activated macrophages during allergic bronchopulmonary mycosis. J Immunol (2005) 1.81
Suppression of Clostridium difficile in the gastrointestinal tracts of germfree mice inoculated with a murine isolate from the family Lachnospiraceae. Infect Immun (2012) 1.79
Interaction between the intestinal microbiota and host in Clostridium difficile colonization resistance. Trends Microbiol (2012) 1.70
Induction of interleukin-12 and gamma interferon requires tumor necrosis factor alpha for protective T1-cell-mediated immunity to pulmonary Cryptococcus neoformans infection. Infect Immun (2002) 1.70
Colonization of the cecal mucosa by Helicobacter hepaticus impacts the diversity of the indigenous microbiota. Infect Immun (2005) 1.67
Widespread colonization of the lung by Tropheryma whipplei in HIV infection. Am J Respir Crit Care Med (2013) 1.66
Macrophage M1/M2 polarization dynamically adapts to changes in cytokine microenvironments in Cryptococcus neoformans infection. MBio (2013) 1.62
The role of the bacterial microbiome in lung disease. Expert Rev Respir Med (2013) 1.62
Relationship between COMLEX and USMLE scores among osteopathic medical students who take both examinations. Teach Learn Med (2010) 1.60
The microbiome of the lung. Transl Res (2012) 1.59
Chronic gastritis in the hypochlorhydric gastrin-deficient mouse progresses to adenocarcinoma. Oncogene (2005) 1.59
Differential roles of CC chemokine ligand 2/monocyte chemotactic protein-1 and CCR2 in the development of T1 immunity. J Immunol (2002) 1.59
Perturbation of the small intestine microbial ecology by streptomycin alters pathology in a Salmonella enterica serovar typhimurium murine model of infection. Infect Immun (2009) 1.59
Interleukin-1beta promotes gastric atrophy through suppression of Sonic Hedgehog. Gastroenterology (2009) 1.58
Antibiotic administration alters the community structure of the gastrointestinal micobiota. Gut Microbes (2010) 1.57
Analysis of the upper respiratory tract microbiotas as the source of the lung and gastric microbiotas in healthy individuals. MBio (2015) 1.56
Role of PLB1 in pulmonary inflammation and cryptococcal eicosanoid production. Infect Immun (2003) 1.55
Depression, antidepressant medications, and risk of Clostridium difficile infection. BMC Med (2013) 1.54
Distinct roles for IL-4 and IL-10 in regulating T2 immunity during allergic bronchopulmonary mycosis. J Immunol (2005) 1.52
Stabilization of the murine gut microbiome following weaning. Gut Microbes (2012) 1.49
Mechanisms of cryptococcal virulence and persistence. Future Microbiol (2010) 1.49
Robust Th1 and Th17 immunity supports pulmonary clearance but cannot prevent systemic dissemination of highly virulent Cryptococcus neoformans H99. Am J Pathol (2009) 1.48
Accumulation of CD11b+ lung dendritic cells in response to fungal infection results from the CCR2-mediated recruitment and differentiation of Ly-6Chigh monocytes. J Immunol (2009) 1.48
Production of eicosanoids and other oxylipins by pathogenic eukaryotic microbes. Clin Microbiol Rev (2003) 1.45
The role of dendritic cells in the development of acute dextran sulfate sodium colitis. J Immunol (2007) 1.45
Microbial ecology of the murine gut associated with the development of dextran sodium sulfate-induced colitis. Inflamm Bowel Dis (2010) 1.44
Novel chemokine responsiveness and mobilization of neutrophils during sepsis. Am J Pathol (2004) 1.42
Impact of enhanced Staphylococcus DNA extraction on microbial community measures in cystic fibrosis sputum. PLoS One (2012) 1.40
Microbiome data distinguish patients with Clostridium difficile infection and non-C. difficile-associated diarrhea from healthy controls. MBio (2014) 1.40
Production of prostaglandins and leukotrienes by pathogenic fungi. Infect Immun (2002) 1.39
CCR2 mediates conventional dendritic cell recruitment and the formation of bronchovascular mononuclear cell infiltrates in the lungs of mice infected with Cryptococcus neoformans. J Immunol (2008) 1.39
Bone morphogenetic protein signaling regulates gastric epithelial cell development and proliferation in mice. Gastroenterology (2010) 1.38
Cryptococcal urease promotes the accumulation of immature dendritic cells and a non-protective T2 immune response within the lung. Am J Pathol (2009) 1.38
The "Microflora Hypothesis" of allergic disease. Adv Exp Med Biol (2008) 1.37
CNLAC1 is required for extrapulmonary dissemination of Cryptococcus neoformans but not pulmonary persistence. Infect Immun (2004) 1.36
Helicobacter acinonychis: genetic and rodent infection studies of a Helicobacter pylori-like gastric pathogen of cheetahs and other big cats. J Bacteriol (2004) 1.35
The gut microbiome in health and in disease. Curr Opin Gastroenterol (2015) 1.33
Role of granulocyte macrophage colony-stimulating factor in host defense against pulmonary Cryptococcus neoformans infection during murine allergic bronchopulmonary mycosis. Am J Pathol (2007) 1.31
Effect of cytokine interplay on macrophage polarization during chronic pulmonary infection with Cryptococcus neoformans. Infect Immun (2011) 1.31
Cefoperazone-treated mice as an experimental platform to assess differential virulence of Clostridium difficile strains. Gut Microbes (2011) 1.29
Mathematical modeling of primary succession of murine intestinal microbiota. Proc Natl Acad Sci U S A (2013) 1.27
The unfolded protein response and chemical chaperones reduce protein misfolding and colitis in mice. Gastroenterology (2013) 1.27
Role of dendritic cells and alveolar macrophages in regulating early host defense against pulmonary infection with Cryptococcus neoformans. Infect Immun (2009) 1.26
Application of a neutral community model to assess structuring of the human lung microbiome. MBio (2015) 1.25
Parietal cell hyperstimulation and autoimmune gastritis in cholera toxin transgenic mice. Am J Physiol Gastrointest Liver Physiol (2006) 1.24
Regulation of Candida albicans morphogenesis by fatty acid metabolites. Infect Immun (2004) 1.24
Helicobacter pylori-secreted factors inhibit dendritic cell IL-12 secretion: a mechanism of ineffective host defense. Am J Physiol Gastrointest Liver Physiol (2006) 1.24
Streptococcus intermedius causing infective endocarditis and abscesses: a report of three cases and review of the literature. BMC Infect Dis (2008) 1.23
Procalcitonin levels associate with severity of Clostridium difficile infection. PLoS One (2013) 1.22
Inheritance of immune polarization patterns is linked to resistance versus susceptibility to Cryptococcus neoformans in a mouse model. Infect Immun (2008) 1.22
Variation of the natural transformation frequency of Campylobacter jejuni in liquid shake culture. Microbiology (2003) 1.21
Pathogenesis of renal disease due to enterohemorrhagic Escherichia coli in germ-free mice. Infect Immun (2008) 1.20
Treatment of Helicobacter gastritis with IL-4 requires somatostatin. Proc Natl Acad Sci U S A (2003) 1.19
Transient neutralization of tumor necrosis factor alpha can produce a chronic fungal infection in an immunocompetent host: potential role of immature dendritic cells. Infect Immun (2005) 1.18
Generation of antifungal effector CD8+ T cells in the absence of CD4+ T cells during Cryptococcus neoformans infection. J Immunol (2005) 1.18
The microbiome in wound repair and tissue fibrosis. J Pathol (2012) 1.18
Hedgehog is an anti-inflammatory epithelial signal for the intestinal lamina propria. Gastroenterology (2010) 1.17
A gene-targeted approach to investigate the intestinal butyrate-producing bacterial community. Microbiome (2013) 1.17
Modulation of host immune responses by the cytolethal distending toxin of Helicobacter hepaticus. Infect Immun (2006) 1.16
The gamma interferon receptor is required for the protective pulmonary inflammatory response to Cryptococcus neoformans. Infect Immun (2005) 1.15
Alteration of the murine gastrointestinal microbiota by tigecycline leads to increased susceptibility to Clostridium difficile infection. Antimicrob Agents Chemother (2014) 1.14
Chemokine receptor 2-mediated accumulation of fungicidal exudate macrophages in mice that clear cryptococcal lung infection. Am J Pathol (2010) 1.14
Effects of tumor necrosis factor alpha on dendritic cell accumulation in lymph nodes draining the immunization site and the impact on the anticryptococcal cell-mediated immune response. Infect Immun (2003) 1.14
The relationship between phenotype, ribotype, and clinical disease in human Clostridium difficile isolates. Anaerobe (2013) 1.14